Michael Grimley

3.9k total citations
117 papers, 1.9k citations indexed

About

Michael Grimley is a scholar working on Hematology, Epidemiology and Oncology. According to data from OpenAlex, Michael Grimley has authored 117 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 31 papers in Epidemiology and 29 papers in Oncology. Recurrent topics in Michael Grimley's work include Hematopoietic Stem Cell Transplantation (42 papers), Virus-based gene therapy research (21 papers) and Cytomegalovirus and herpesvirus research (19 papers). Michael Grimley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (42 papers), Virus-based gene therapy research (21 papers) and Cytomegalovirus and herpesvirus research (19 papers). Michael Grimley collaborates with scholars based in United States, Canada and United Kingdom. Michael Grimley's co-authors include Stella M. Davies, Sonata Jodele, Christopher E. Dandoy, Kasiani C. Myers, Javier El‐Bietar, Adam Lane, Pooja Khandelwal, Jack Bleesing, Rebecca Marsh and Ashish Kumar and has published in prestigious journals such as Blood, Radiology and Journal of the American Society of Nephrology.

In The Last Decade

Michael Grimley

113 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Grimley United States 22 869 626 369 332 296 117 1.9k
Prakash Satwani United States 28 1.0k 1.2× 474 0.8× 550 1.5× 268 0.8× 453 1.5× 138 2.1k
Kazuteru Ohashi Japan 27 1.4k 1.6× 439 0.7× 448 1.2× 288 0.9× 227 0.8× 130 2.1k
Minoo Battiwalla United States 28 1.2k 1.4× 727 1.2× 680 1.8× 658 2.0× 459 1.6× 142 2.6k
Robert Chiesa United Kingdom 25 657 0.8× 529 0.8× 621 1.7× 307 0.9× 148 0.5× 61 1.7k
Karl‐Walter Sykora Germany 20 755 0.9× 580 0.9× 518 1.4× 355 1.1× 171 0.6× 45 2.2k
Maura Faraci Italy 26 831 1.0× 363 0.6× 695 1.9× 468 1.4× 163 0.6× 121 2.2k
Jaime Sanz Spain 27 1.6k 1.9× 460 0.7× 791 2.1× 372 1.1× 356 1.2× 191 2.5k
Shelly L. Carter United States 20 1.6k 1.9× 644 1.0× 639 1.7× 572 1.7× 441 1.5× 30 2.3k
Richard Champlin United States 15 870 1.0× 351 0.6× 325 0.9× 299 0.9× 208 0.7× 32 1.5k
Roberto Crocchiolo Italy 27 1.2k 1.3× 661 1.1× 587 1.6× 553 1.7× 211 0.7× 111 2.1k

Countries citing papers authored by Michael Grimley

Since Specialization
Citations

This map shows the geographic impact of Michael Grimley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Grimley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Grimley more than expected).

Fields of papers citing papers by Michael Grimley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Grimley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Grimley. The network helps show where Michael Grimley may publish in the future.

Co-authorship network of co-authors of Michael Grimley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Grimley. A scholar is included among the top collaborators of Michael Grimley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Grimley. Michael Grimley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2025). Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. 31(10). 826.e1–826.e10. 1 indexed citations
2.
3.
Grimley, Michael, Tom Leemhuis, José A. Cancelas, et al.. (2024). Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 24(9). 1634–1643. 13 indexed citations
4.
Apewokin, Senu, et al.. (2023). Viral specific T cell therapy in kidney transplant recipients – A single‐center experience. Transplant Infectious Disease. 25(6). e14179–e14179. 5 indexed citations
5.
6.
Rubinstein, Jeremy D., Carolyn Lutzko, Tom Leemhuis, et al.. (2021). Scheduled Donor-Derived Viral Specific T-Cells for Prophylaxis Against Double Stranded DNA Viral Infection after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(3). S87–S88. 1 indexed citations
7.
Teusink‐Cross, Ashley, Kasiani C. Myers, Stella M. Davies, et al.. (2021). Ruxolitinib for the Treatment of Chronic GVHD in Children and Young Adults. Transplantation and Cellular Therapy. 27(3). S257–S258. 1 indexed citations
8.
Grimley, Michael, Monika Asnani, Archana Shrestha, et al.. (2021). Safety and Efficacy of Aru-1801 in Patients with Sickle Cell Disease: Early Results from the Phase 1/2 Momentum Study of a Modified Gamma Globin Gene Therapy and Reduced Intensity Conditioning. Blood. 138(Supplement 1). 3970–3970. 21 indexed citations
9.
Rubinstein, Jeremy D., Sonata Jodele, Jamie Wilhelm, et al.. (2021). Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 28(2). 116.e1–116.e7. 17 indexed citations
10.
11.
Chandra, Sharat, Shanmuganathan Chandrakasan, Blachy J. Dávila Saldaña, et al.. (2020). Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation. Journal of Clinical Immunology. 41(1). 89–98. 13 indexed citations
12.
Sabulski, Anthony, Stella M. Davies, Grant Paulsen, et al.. (2020). Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant. Journal of Clinical Immunology. 40(8). 1171–1175. 2 indexed citations
13.
Gloude, Nicholas J., Sonata Jodele, Ashley Teusink‐Cross, et al.. (2017). Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 24(1). 91–95. 8 indexed citations
14.
Teusink‐Cross, Ashley, Stella M. Davies, Lara Danziger‐Isakov, Javier El‐Bietar, & Michael Grimley. (2016). Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients. Biology of Blood and Marrow Transplantation. 22(10). 1904–1906. 9 indexed citations
15.
Grimley, Michael, Gabriela Marón, Vinod K. Prasad, et al.. (2015). Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. Biology of Blood and Marrow Transplantation. 21(2). S108–S109. 7 indexed citations
16.
Chandrakasan, Shanmuganathan, Rebecca Marsh, Michael Grimley, et al.. (2013). Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience. Biology of Blood and Marrow Transplantation. 19(2). S284–S284. 1 indexed citations
17.
Kamani, Naynesh, Mark C. Walters, Shelly Carter, et al.. (2012). Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biology of Blood and Marrow Transplantation. 18(8). 1265–1272. 142 indexed citations
18.
Jacobsohn, David A., Andrew L. Gilman, Alfred Rademaker, et al.. (2009). Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study. Blood. 114(20). 4354–4360. 28 indexed citations
19.
Bachier, Carlos, Paul Shaughnessy, César O. Freytes, et al.. (2005). Efficacy of fluconazole prophylaxis for autologous peripheral blood stem cell transplantation: Results of a prospective, randomized, controlled, multicenter, open label study. Biology of Blood and Marrow Transplantation. 11(2). 106–106. 1 indexed citations
20.
Shaughnessy, Paul, Carlos Bachier, Michael Grimley, & CF LeMaistre. (2003). 110Phase II study of denileukin diftitox (Ontak) in the treatement of steroid resistant acute graft versus host disease (AGVHD). Biology of Blood and Marrow Transplantation. 9(2). 98–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prakash Satwani Breakdown of academic impact, for papers by Kazuteru Ohashi Breakdown of academic impact, for papers by Minoo Battiwalla Breakdown of academic impact, for papers by Robert Chiesa Breakdown of academic impact, for papers by Karl‐Walter Sykora Breakdown of academic impact, for papers by Maura Faraci Breakdown of academic impact, for papers by Jaime Sanz Breakdown of academic impact, for papers by Shelly L. Carter Breakdown of academic impact, for papers by Richard Champlin Breakdown of academic impact, for papers by Roberto Crocchiolo
Rankless by CCL
2026